文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

社区社会经济剥夺、医疗可及性与脓毒症或危重病后30天死亡率及再入院:一项全国性研究

Neighborhood socioeconomic deprivation, healthcare access, and 30-day mortality and readmission after sepsis or critical illness: findings from a nationwide study.
PubMed 文献 · Crit Care · 2023-07-15
一句话结论在医保人群中,社区社会经济剥夺独立预测脓毒症或危重病后30天死亡率升高(ADI最高 vs 最低:脓毒症OR 1.35,延长机械通气OR 1.42),不增加再入院。

该研究基于美国2017至2019年 Medicare 受益人全国数据,通过诊断相关组识别严重脓毒症及需延长机械通气、气管切开或 ECMO 的住院患者。以区域剥夺指数(ADI)衡量社区社会经济剥夺,采用限制性立方样条 logistic 回归,序贯调整人口学、个体贫困、合并症、医疗可及性及收治医院特征。结果显示,与 ADI 1 社区相比,ADI 100 社区患者30天死亡率在严重脓毒症(OR 1.35,95%CI 1.29-1.42)和延长机械通气(OR 1.42,95%CI 1.31-1.54)中均更高,呈线性剂量依赖。社区剥夺与严重脓毒症30天非计划再入院无关,与延长机械通气患者再入院呈负相关。结论提示,社区剥夺对危重患者30天死亡率的强关联不能由个体贫困、人口学、基线医学风险、医疗可及性或医院特征解释。

要点

  • 在严重脓毒症幸存者中,居住于 ADI 100(最剥夺)社区者30天死亡率高于 ADI 1(最不剥夺)社区者(OR 1.35,95%CI 1.29-1.42),独立于个体贫困、医疗可及性和医院特征。
  • 在需延长机械通气(伴或不伴脓毒症)的患者中,ADO 100 社区者30天死亡率同样更高(OR 1.42,95%CI 1.31-1.54),且关联呈线性剂量依赖。
  • 社区社会经济剥夺与严重脓毒症患者30天非计划再入院无关,与延长机械通气患者再入院呈负相关。

适用人群与场景

  • 美国2017至2019年 Medicare 受益人,因严重脓毒症住院或需延长机械通气、气管切开或 ECMO 的住院患者。

诊断标准与关键阈值

  • 通过诊断相关组(DRGs)识别严重脓毒症及需延长机械通气、气管切开或 ECMO 的患者。
  • 社区社会经济剥夺以区域剥夺指数(ADI)衡量,ADI 1 为最不剥夺社区,ADI 100 为最剥夺社区。

研究设计与关键结果

  • 全国性研究纳入1,526,405例次入院进行死亡率分析,1,354,548例次入院进行再入院分析。
  • 充分调整后,与 ADI 1 社区相比,ADI 100 社区严重脓毒症患者30天死亡率更高(OR 1.35,95%CI 1.29-1.42)。
  • 充分调整后,与 ADI 1 社区相比,ADI 100 社区需延长机械通气(伴或不伴脓毒症)患者30天死亡率更高(OR 1.42,95%CI 1.31-1.54)。
  • 社区社会经济剥夺与30天死亡率的关联呈线性且剂量依赖。
  • 社区社会经济剥夺与严重脓毒症患者30天非计划再入院无关。
  • 社区社会经济剥夺与需延长机械通气(伴或不伴脓毒症)患者30天非计划再入院呈负相关。

证据类型、等级与局限

  • 研究类型:基于美国 Medicare 受益人的全国性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,社区社会经济剥夺与危重患者30天死亡率的强关联不能由个体贫困、人口学、基线医学风险、医疗可及性或收治医院特征解释。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: To determine if neighborhood socioeconomic deprivation independently predicts 30-day mortality and readmission for patients with sepsis or critical illness after adjusting for individual poverty, demographics, comorbidity burden, access to healthcare, and characteristics of treating healthcare facilities.

METHODS: We performed a nationwide study of United States Medicare beneficiaries from 2017 to 2019. We identified hospitalized patients with severe sepsis and patients requiring prolonged mechanical ventilation, tracheostomy, or extracorporeal membrane oxygenation (ECMO) through Diagnosis Related Groups (DRGs). We estimated the association between neighborhood socioeconomic deprivation, measured by the Area Deprivation Index (ADI), and 30-day mortality and unplanned readmission using logistic regression models with restricted cubic splines. We sequentially adjusted for demographics, individual poverty, and medical comorbidities, access to healthcare services; and characteristics of treating healthcare facilities.

RESULTS: A total of 1,526,405 admissions were included in the mortality analysis and 1,354,548 were included in the readmission analysis. After full adjustment, 30-day mortality for patients was higher for those from most-deprived neighborhoods (ADI 100) compared to least deprived neighborhoods (ADI 1) for patients with severe sepsis (OR 1.35 95% [CI 1.29-1.42]) or with prolonged mechanical ventilation with or without sepsis (OR 1.42 [95% CI 1.31, 1.54]). This association was linear and dose dependent. However, neighborhood socioeconomic deprivation was not associated with 30-day unplanned readmission for patients with severe sepsis and was inversely associated with readmission for patients requiring prolonged mechanical ventilation with or without sepsis.

CONCLUSIONS: A strong association between neighborhood socioeconomic deprivation and 30-day mortality for critically ill patients is not explained by differences in individual poverty, demographics, measured baseline medical risk, access to healthcare resources, or characteristics of treating hospitals.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Lusk JB, Blass B, Mahoney H, et al. Neighborhood socioeconomic deprivation, healthcare access, and 30-day mortality and readmission after sepsis or critical illness: findings from a nationwide study. Crit Care. 2023. PMID: 37454127. doi:10.1186/s13054-023-04565-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。